Case Report: Efficacy of ofatumumab in refractory anti-NMDAR encephalitis: case series and literature review
Anti-NMDAR encephalitis is the most common autoimmune encephalitis. When first-line treatments fail, second-line therapies are employed. However, a standardized approach for second-line treatment has yet to be established. We presented three cases of anti-NMDAR encephalitis with seizures and psychos...
Main Authors: | , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2025-03-01
|
Series: | Frontiers in Immunology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fimmu.2025.1557210/full |